Post-ischemic azotemia as a partial ‘brake’ slowing progressive kidney disease

摘要

BackgroundRecent experimental work suggests a paradox: although uremia evokes systemic toxicities, in the setting of AKI, it can induce intrarenal cytoprotective and anti-inflammatory effects. Whether these influences can attenuate post-ischemic kidney disease progression remains unknown.